黛力新对良性阵发性位置性眩晕复位成功后残留症状的疗效评估.docVIP

精品论文 参考文献 黛力新对良性阵发性位置性眩晕复位成功后残留症状的疗效评估 南充市第五人民医院 637000 【摘 要】目的：评价抗常规剂量黛力新对CRP治疗成功后残留症状的疗效。方法：2015年10月～2016年5月期间44例BPPV患者接受CRP治疗成功后，随机分为药物组和对照组。药物组患者服用黛力新常规剂量5日，对照组患者不用药。所有患者在5日后复诊，采用头晕残障量表（DHI）评价CRP治疗前后及药物治疗后的主观症状变化。结果：两组患者的DHI得分均显著下降，药物组患者在CRP治疗后5日DHI分量表分数下降更加显著。结论：本研究表明，黛力新加快了CRP后残留症状的恢复。 【关键词】良性阵发性位置性眩晕；管石复位；抗焦虑药物； Therapeutic effect evaluation on remnant symptome after Canalith Repositioning Procedure（CRP）by Deanxit to treat benign paroxysmal positional vertigo Long Shi-yu*，He Lin，Pu Song-lin，Zhao Min，Luo Xue-dong，Chen Jin-li. Department of Neurology，Nanchong Fifth Peoplersquo;s Hospital，Nanchong 637000，China Corresponding author：LONG Shi-yu，E-mail：longshiyu2014@ 【Abstract】Objective：Evaluate the curative effect of adjuvant therapy of anti-anxiety drug Deanxit on residual dizziness after successful CRP treatment. Method：44 cases of BPPV patients were successfully treated with CRP from October 2015 to May 2016，they patients were divided into drug group and control group. The patients of drug group took conventional dose of Deanxit for five days while the control group did not take any drugs. All patients took reexamination after 5 days. The subjective symptom change before CRP treatment and after drug therapy was evaluated with DHI. Result：The DHI scores of the two groups reduced significantly. The DHI score of drug group reduced more significantly after treated with CRP for 5 days.Conclusion：The study indicates that Deanxit accelerated the recovery of residual symptoms after treatment with CRP. 【Key words】Benign paroxysmal positional vertigo；Canalith repositioning procedure；Anxiolytics； 【中图分类号】R255.3 【文献标识码】A 【文章编号】2096-0867（2016）09-015-03 良性阵发性位置性眩晕（BPPV）是最常见的前庭外周性病变之一，占神经耳科门诊所有诊断的20%～30%[1]，临床表现为由头位变化引起的眩晕和眼震[2]。1992年，Epley提出了耳石复位法（CRP）[3]，是治疗BPPV的主要方法[4]，美国耳鼻喉头颈外科BPPV指南和美国神经内科学会BPPV指南均将其列为首选。大约85%～90%的BPPV患者通过耳石复位可以完全治愈或显著改善[5-6]。根据脱落耳石位置的不同有多种不同的CRP方法[7]。合适的CRP能够迅速减轻BPPV患者的症状并且疗效持久，但许多患者在CRP治疗成功后，虽然眩晕和眼震消失，但仍有部分残留症状，如：非特异性的头晕、漂浮感和焦虑。既往研究发现，